cefazolin has been researched along with Weight Loss in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dhert, WJ; Fleer, A; Nijhof, MW; Schouls, LM; Stallmann, HP; Verbout, AJ; Vogely, HC | 1 |
Harlan, JM; Mileski, WJ; Rice, CL; Winn, RK | 1 |
2 other study(ies) available for cefazolin and Weight Loss
Article | Year |
---|---|
Prevention of infection with tobramycin-containing bone cement or systemic cefazolin in an animal model.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthritis, Infectious; Blood Sedimentation; Bone Cements; Cefazolin; Cephalosporins; DNA, Bacterial; Drug Evaluation, Preclinical; Female; Femur; Injections, Intravenous; Materials Testing; Methylmethacrylate; Models, Animal; Polymerase Chain Reaction; Prosthesis-Related Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Weight Loss | 2000 |
Transient inhibition of neutrophil adherence with the anti-CD18 monoclonal antibody 60.3 does not increase mortality rates in abdominal sepsis.
Topics: Abdomen; Animals; Antibodies, Monoclonal; Ascitic Fluid; Bacterial Infections; Cefazolin; Cell Adhesion; Neutrophils; Rabbits; Survival Rate; Weight Loss | 1991 |